| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viking Therapeutics, Inc. (VKTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. VKTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $85.66M | -148,517 | |
| COO | 422.8K | $14.08M | -18,217 | |
| CFO | 212.2K | $7.07M | -21,217 | |
| Dir | 148.0K | $4.93M | - | |
| Dir | 51.1K | $1.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30, 2024 | Lian Brian52 | President &CEO | Sell | 115,859 | $57.58 | $6,670,604.02 | -1.6% | +31.8% | -40.4% | |
| Jul 30, 2024 | Mancini Marianna53 | Chief Operating Officer | Sell | 18,026 | $57.13 | $1,029,911.96 | -2.4% | +31.8% | -40.4% | |
| May 3, 2024 | Zante Greg53 | Chief Financial Officer | Sale+OE | 66,756 | $74.69 | $4,986,007.97 | -7.9% | -29.0% | -61.9% | |
| May 1, 2024 | Mancini Marianna53 | Chief Operating Officer | Sale+OE | 281,425 | $78.66 | $22,136,473.80 | -10.6% | -26.0% | -62.6% | |
| Feb 9, 2024 | Lian Brian52 | President &CEO | Sell | 45,000 | $29.90 | $1,345,500.00 | -2.1% | +162.3% | +6.5% | |
| Feb 8, 2024 | Lian Brian52 | President &CEO | Sale+OE | 269,079 | $26.87 | $7,230,784.25 | -2.3% | +176.6% | +12.7% | |
| Feb 8, 2024 | Rouan Sarah Kathryn49 | Director | Sale+OE | 25,000 | $28.05 | $701,250.00 | -100% | +176.6% | +12.7% | |
| Jan 31, 2024 | Lian Brian52 | President &CEO | Sale+OE | 85,000 | $24.71 | $2,100,750.00 | -1.8% | +229.7% | +39.6% | |
| Jan 30, 2024 | Lian Brian52 | President &CEO | Sale+OE | 35,000 | $23.95 | $838,250.00 | -1.5% | +216.6% | +40.3% | |
| Jan 19, 2024 | Rouan Sarah Kathryn49 | Director | Sale+OE | 30,000 | $23.05 | $691,500.00 | -100% | +197.1% | +50.0% |